Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

An AI-based IoT medical device revolutionizing motor recovery following neurological disorders, inspiring hope and helping patients and their families regain their independence.

Descripción del proyecto

Un producto sanitario con inteligencia artificial para la curación de trastornos neurológicos

Las discapacidades motoras representan una quinta parte de los trastornos neurológicos en todo el mundo y reducen significativamente la independencia de los enfermos. La lesión de médula espinal (LME) figura entre las discapacidades con un nivel más bajo de curación total, especialmente cuando ocurre a una edad temprana. Con todo, no existe una solución de recuperación real, lo que lleva a tratamientos que tienen un potencial de recuperación limitado, son caros, requieren mucho tiempo y representan una carga enorme para los sistemas sanitarios. El proyecto financiado con fondos europeos BQ System propone una herramienta médica avanzada del internet de las cosas que favorece la rehabilitación neurológica. El dispositivo está dirigido a casos de parálisis debido a una LME o un accidente cerebrovascular y emplea capacidades de inteligencia artificial para diseñar un tratamiento personalizado de campo electromagnético de baja intensidad que aumenta el potencial de recuperación. Este producto sanitario está conectado a la nube, no es invasivo y es cómodo y fácil de usar.

Objetivo

Neurological disorders affect over a billion people worldwide, of which 200 million suffer from motor disabilities which substantially impact on their lives. One example of a common neurodisorder is spinal cord injury, where less than 1% of patients experience complete neurologic recovery. when SCI occurs in young age it leaves people to live a whole life of paralysis. Many of these patients will be left dependent on others, unable to perform activities of daily living, and likely be unemployed. To date, there is no real available solution for full recovery. The current standard of treatment, physical therapy, is typically tedious and offers limited recovery potential. In addition to providing minimal results, the present treatment regimens are costly, time-consuming, cumbersome, and require the regular movement of patients between multiple care providers, prompting the need for emerging neurorecovery technologies. With growing numbers, neurological disorders create tremendous pressure on healthcare institutions which are already strained for resources.

BrainQ has developed the BQ System, an innovative IoT medical device to promote neurorecovery. The company's first indication is facilitating motor recovery following paralysis as a result of SCI or stroke. The BQ System implements AI capabilities to tailor a low-intensity electromagnetic field (EMF) treatment for each patient, maximizing their recovery potential for motor function improvement. Treatment with the BQ Device is non-invasive, and is comfortable for patients. It is also cloud-connected with a user-friendly interface.

This project will allow BQ System advance to a home-care protocol, allowing integration with other treatments as well as future vertical scaling to reach patients suffering from motor impairment due to a wide range of neurological disorders. BrainQ will perform engineering optimisation, industrialization, and clinical validation of the BQ System.

Convocatoria de propuestas

H2020-EIC-SMEInst-2018-2020

Consulte otros proyectos de esta convocatoria

Convocatoria de subcontratación

H2020-EIC-SMEInst-2018-2020-3

Coordinador

BRAINQ TECHNOLOGIES LTD
Aportación neta de la UEn
€ 2 248 727,00
Dirección
4/4 HIGH TECH VILLAGE GIVAT RAM
39129 JERUSALEM
Israel

Ver en el mapa

Pyme

Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.

Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total
€ 3 212 467,14